Dr. Jason Taylor Silberman, MD

Dr. Silberman practices at Hancock Regional Hospital in Greenfield, Indiana, part of Hancock Health.

Dr. Silberman's NPI, 1073046363, was assigned on April 4, 2017. Dr. Silberman holds Tennessee license 58623.

Dr. Silberman's primary practice is Hancock Regional Hospital, at 801 N State St, Greenfield, IN 46140 in Hancock County. The practice phone is (317) 462-5544.

Dr. Silberman's primary practice is Hancock Regional Hospital in Greenfield, Indiana, part of Hancock Health. Dr. Silberman is also affiliated with Ascension St. Vincent Hospital - Indianapolis. The medical group on file is Vituity. Dmand AI also links Dr. Silberman to 2 more hospitals, 5 medical groups, 1 clinical lab and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Silberman practices, 6 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Silberman's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Silberman's licenses on file in 2 states: Tennessee and Indiana.

CMS data shows 961 Medicare services from Dr. Silberman across 5 procedure codes in 2024, for 849 Medicare patients. Medicare paid $98,066 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 849 Medicare patients who saw Dr. Silberman in 2024. The largest group is 75 to 84, with 313 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Silberman's median patient age at 52, with 56% women.

In 2024, Dr. Silberman wrote 333 Medicare Part D claims for 235 patients. 97% of them were for generic drugs. CMS names the drug for 204 of them, across 9 drugs with 11 or more claims each, at $1,255 in total drug cost. In 2023, CMS named 143 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Silberman for performance year 2024, reported individually. Dr. Silberman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Dr. Silberman from 4 drug and device companies from 2022 to 2023. Food and beverage make up the largest share, 100% of the total. CSL Behring paid the most, $34.